Differential effects of the dopamine D2/D3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens

Psychopharmacology

Volumn 160, Issue 3, 2002, Pages 307-317

  David, Vincent ^a   Durkin, Thomas P ^a   Cazala, Pierre ^a  

^a CNRS   (France)

Author keywords

D2 and D3 receptors; Dopamine; Intracranial self administration; Morphine; Mouse; Nucleus accumbens; Ventral tegmental area

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; MORPHINE; NEUROLEPTIC AGENT; STAINLESS STEEL; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANNULA; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG INFUSION; DRUG SELF ADMINISTRATION; IMPLANTATION; MALE; MAZE TEST; MICROINJECTION; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; REINFORCEMENT; SENSITIZATION; VENTRAL TEGMENTUM;

ANIMALS; DOPAMINE ANTAGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED BALB C; MORPHINE; NARCOTICS; NUCLEUS ACCUMBENS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SELF ADMINISTRATION; SULPIRIDE; VENTRAL TEGMENTAL AREA;

EID: 0036120723     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-001-0981-2     Document Type: Article

References (83)

1. SCH 23390 blocks drug-conditioned place-preference and place-aversion: Anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?
2. Neuropharmacological mechanisms of drug reward: Beyond dopamine in the nucleus accumbens
3. Functional heterogeneity in dopamine release and in the expression of fos-like proteins within the rat striatal complex
4. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area
5. Neuroanatomical boundaries of the reward-relevant opiate receptors field in the ventral tegmental area as mapped by the conditioned place preference method
6. Heroin reward is dependent on a dopaminergic substrate
7. Intracranial self administration of morphine into the ventral tegmental area
8. Separation of inhibiting and stimulating effects of morphine on self-stimulation behavior by intracerebral mircroinjections
9. Self-administration of morphine into the lateral hypothalamus in the mouse
10. Dopamine depletion produces augmented behavioural responses to a mu- but not delta-opioid receptor agonist in the nucleus accumbens
11. Evidence for opiate-dopa-mine cross-sensitization in nucleus accumbens: Studies of conditioned reward
12. Opiate infusion into nucleus accumbens: Contrasting effects on motor activity and responding for conditioned reward
13. A comparative study of self administration of morphine into the amygdala and the ventral tegmental area in mice
14. Preference for self administration of a low dose of morphine into the ventral tegmental area rather than into the amygdala in mice
15. Anatomical and pharmacological specificity of the rewarding effect of microinjections of morphine into the nucleus accumbens of mice
16. 2 dopaminergic mechanism
17. Rewarding effects elicited by the microinjection of either AMPA or NMDA glutamatergic antagonists into the ventral tegmental area revealed by an intracranial self-administration paradigm in mice
18. Differential involvement of ventral tegmental mu, delta and kappa opioids receptors in modulation of basal mesolimbic dopamine release: In vivo microdialysis study
19. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
20. Autoradiographic localization of μ-opioid and neurotensin receptors within the mesolimbic dopamine system
21. Autoradiographic localization of μ-opioid receptors within the mesocorticolimbic dopamine system using radioionated [2-d-penicillamine, 5-d-penicilla-mine] enkephaline (125 I-DPDPE)
22. Lack of an effect of 6-hydroxydopamine lesions of the nucleus accumbens on intravenous morphine self administration
23. Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems
24. Morphine-induced activation of A10 dopamine neurons in the rat
25. Opiates influence on nucleus accumbens electrophysiology/dopamine and non deopamine mechanisms
26. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex
27. The effects of intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis
28. 2 receptors in the nucleus accumbens in mediating reward
29. Self infusion of GABA(A) antagonist directly into the ventral tegmental area and adjacent regions
30. Effects of dopamine D2/D3 receptor antagonist sulpiride on amphetamine-induced changes in striatal extracellular dopamine
31. Dopamine receptor antagonists prevent expression, but not development of morphine sensitization
32. Opioids excite dopamine neurons by hyperpolarization of local interneurons
33. Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin
34. Sensitization to repeated morphine injection in the rat: Possible involvement of A10 dopamine neurons
35. Enkephalin action on the mesolimbic system: A dopamine-dependent and a dopamine-independent increase in locomotor activity
36. Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous heroin self-administration in rats
37. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA
38. Schizophrenia and psychostimulant abuse: A review and re-analysis of clinical evidence
39. 1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning
40. Morphine-dopamine interaction: Ventral tegmental morphine increases nucleus accumbens dopamine release
41. Morphine induced c-fos and junB in the striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors
42. 2 receptors
43. Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine
44. Localization of brain reinforcement mechanism: Intracranial self-administration and intracranial place conditioning studies
45. Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions
46. Differences in effects of sultopride and sulpiride on dopamine turnover in rat brain
47. Deprivation switches the neurobiological substrates mediating opiate reward in the ventral tegmental area
48. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: A review
49. Reinforcing effects of morphine in the nucleus accumbens
50. The development of a conditioned place preference to morphine: Effects of microinjections into various CNS sites
51. Effects of local delta and mu-opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: In vivo electrochemical study
52. Neuroanatomical focus for morphine and enkephaline-induced hypermotility
53. Further evidence for a role of delta-opioid receptors in the presynaptic regulation of newly synthetized dopamine release
54. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats
55. Reinforcing effects of morphine micro-injections into the ventral tegmental area
56. Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer
57. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment
58. Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats
59. Receptor subtypes in opioids and stimulant reward
60. The neurobiology of opiate reinforcement
61. 2 receptor antagonists
62. 2 dopamine receptors
63. Effects of 6-OHDA lesions of the central medial nucleus accumbens on rat intravenous morphine self administration
64. The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study
65. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system
66. A comparison of the effects of intra-accumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior
67. Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioral supersensitivity to opiates
68. Chronic treatment with five neuroleptics elicit behavioral supersensitivity to opiate infusion into the nucleus accumbens
69. Interaction between endogenous opioids and dopamine within the nucleus accumbens
70. Mu-opioid receptors are localized to extrasynaptic plasma membranes of GABAergic neurons and their targets in the rat nucleus accumbens
71. Striatal opiate mu-receptors are not located on dopamine nerve endings in the rat
72. Characterization of opioid receptors in rat nucleus accumbens following mesolimbic dopaminergic lesions
73. Structure and function of dopamine receptors
74. Involvement of neurohypophyseal peptides in drug-mediated adaptive responses
75. Opioids, reward and addiction: An encounter of biology, psychology, and medecine
76. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist DAGO, administered repeatedly to the ventral tegmental area but not the nucleus accumbens
77. Self administration of small amounts of morphine through glass micropipettes into the ventral tegmental area of the rat
78. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons
79. 2 into nucleus accumbens
80. Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration
81. 2-opioid receptors